Literature DB >> 25484230

Optimization of the crystallizability of a single-chain antibody fragment.

Jana Škerlová1, Vlastimil Král1, Milan Fábry1, Juraj Sedláček1, Václav Veverka2, Pavlína Rezáčová1.   

Abstract

Single-chain variable antibody fragments (scFvs) are molecules with immense therapeutic and diagnostic potential. Knowledge of their three-dimensional structure is important for understanding their antigen-binding mode as well as for protein-engineering approaches such as antibody humanization. A major obstacle to the crystallization of single-chain variable antibody fragments is their relatively poor homogeneity caused by spontaneous oligomerization. A new approach to optimization of the crystallizability of single-chain variable antibody fragments is demonstrated using a representative single-chain variable fragment derived from the anti-CD3 antibody MEM-57. A Thermofluor-based assay was utilized to screen for optimal conditions for antibody-fragment stability and homogeneity. Such an optimization of the protein storage buffer led to a significantly improved ability of the scFv MEM-57 to yield crystals.

Entities:  

Keywords:  Thermofluor assay; crystallizability optimization; crystallization; differential scanning fluorimetry; oligomerization; single-chain antibody fragment

Mesh:

Substances:

Year:  2014        PMID: 25484230      PMCID: PMC4259244          DOI: 10.1107/S2053230X1402247X

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  31 in total

1.  scFv multimers of the anti-neuraminidase antibody NC10: length of the linker between VH and VL domains dictates precisely the transition between diabodies and triabodies.

Authors:  J L Atwell; K A Breheney; L J Lawrence; A J McCoy; A A Kortt; P J Hudson
Journal:  Protein Eng       Date:  1999-07

2.  Domain interactions in antibody Fv and scFv fragments: effects on unfolding kinetics and equilibria.

Authors:  M Jäger; A Plückthun
Journal:  FEBS Lett       Date:  1999-12-03       Impact factor: 4.124

3.  pSKAP/S: An expression vector for the production of single-chain Fv alkaline phosphatase fusion proteins.

Authors:  R A Griep; C van Twisk; R J Kerschbaumer; K Harper; L Torrance; G Himmler; J M van der Wolf; A Schots
Journal:  Protein Expr Purif       Date:  1999-06       Impact factor: 1.650

4.  The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility.

Authors:  Jennifer A Carmichael; Barbara E Power; Thomas P J Garrett; Paul J Yazaki; John E Shively; Andrew A Raubischek; Anna M Wu; Peter J Hudson
Journal:  J Mol Biol       Date:  2003-02-14       Impact factor: 5.469

5.  Crystal structure of a cross-reaction complex between an anti-HIV-1 protease antibody and an HIV-2 protease peptide.

Authors:  Pavlina Rezacova; Jiri Brynda; Julien Lescar; Milan Fabry; Magda Horejsi; Irena Sieglova; Juraj Sedlacek; Graham A Bentley
Journal:  J Struct Biol       Date:  2005-03       Impact factor: 2.867

6.  Thermofluor-based high-throughput stability optimization of proteins for structural studies.

Authors:  Ulrika B Ericsson; B Martin Hallberg; George T Detitta; Niek Dekker; Pär Nordlund
Journal:  Anal Biochem       Date:  2006-08-10       Impact factor: 3.365

7.  Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.

Authors:  K M Arndt; K M Müller; A Plückthun
Journal:  Biochemistry       Date:  1998-09-15       Impact factor: 3.162

8.  High level production of soluble single chain antibodies in small-scale Escherichia coli cultures.

Authors:  S M Kipriyanov; G Moldenhauer; M Little
Journal:  J Immunol Methods       Date:  1997-01-15       Impact factor: 2.303

9.  Multivalent Fvs: characterization of single-chain Fv oligomers and preparation of a bispecific Fv.

Authors:  M Whitlow; D Filpula; M L Rollence; S L Feng; J F Wood
Journal:  Protein Eng       Date:  1994-08

10.  Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

Authors:  J S Huston; D Levinson; M Mudgett-Hunter; M S Tai; J Novotný; M N Margolies; R J Ridge; R E Bruccoleri; E Haber; R Crea
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.